Literature DB >> 24533757

Clinical use of electrode differentiation to enhance programming of cochlear implants.

Shaza M Saleh, Shakeel R Saeed, Leah Meerton, David R Moore, Deborah A Vickers.   

Abstract

The effect of deactivating indiscriminable cochlear implant (CI) electrodes for unilaterally implanted adults was evaluated using the BKB (Bamford-Kowal-Bench) sentence test in quiet and in pink noise (signal-to-noise ratio of +10dBA) and the adaptive Coordinate Response Measure (CRM). Each CI recipient who failed electrode differentiation (ED) in at least one electrode-pair, based on results of a pure-tone pitch-ranking task received two research programmes to try out in a cross-over study. Research programmes (RP) either employed discriminable electrodes only or the most discriminable two-thirds of the electrodes in the electrode array for CI recipients failing ED for more than a third of the electrodes. The participants were also asked to subjectively report improvement of or decline in sound quality in everyday listening situations. There was significant improvement in CRM speech reception thresholds (SRTs) (Z = -3.24, N = 15, P = 0.001), BKB sentence scores in quiet (t = 3.17, df = 24, P < 0.005) and also in pink noise (t = 2.26, df = 19, P < 0.005) after deactivating indiscriminable electrodes.

Entities:  

Keywords:  CI; Cochlear implant; Cochlear implant fitting; Dead region; Electrode deactivation; Electrode differentiation; Electrode discrimination; Electrode switch off; Improving performance; Indiscriminable electrode; Pitch ranking; Speech perception

Mesh:

Year:  2013        PMID: 24533757     DOI: 10.1179/1467010013Z.000000000125

Source DB:  PubMed          Journal:  Cochlear Implants Int        ISSN: 1467-0100


  9 in total

1.  Deactivating cochlear implant electrodes to improve speech perception: A computational approach.

Authors:  Elad Sagi; Mario A Svirsky
Journal:  Hear Res       Date:  2018-10-19       Impact factor: 3.208

2.  The Effect of Advanced Age on the Electrode-Neuron Interface in Cochlear Implant Users.

Authors:  Jeffrey Skidmore; Brittney L Carter; William J Riggs; Shuman He
Journal:  Ear Hear       Date:  2021-12-21       Impact factor: 3.562

3.  Using the electrically-evoked compound action potential (ECAP) interphase gap effect to select electrode stimulation sites in cochlear implant users.

Authors:  Kara C Schvartz-Leyzac; Teresa A Zwolan; Bryan E Pfingst
Journal:  Hear Res       Date:  2021-04-28       Impact factor: 3.672

4.  Reducing Channel Interaction Through Cochlear Implant Programming May Improve Speech Perception: Current Focusing and Channel Deactivation.

Authors:  Julie A Bierer; Leonid Litvak
Journal:  Trends Hear       Date:  2016-06-17       Impact factor: 3.293

5.  Comparing Rapid and Traditional Forward-Masked Spatial Tuning Curves in Cochlear-Implant Users.

Authors:  Heather A Kreft; Lindsay A DeVries; Julie G Arenberg; Andrew J Oxenham
Journal:  Trends Hear       Date:  2019 Jan-Dec       Impact factor: 3.293

6.  A Site-Selection Strategy Based on Polarity Sensitivity for Cochlear Implants: Effects on Spectro-Temporal Resolution and Speech Perception.

Authors:  Tobias Goehring; Alan Archer-Boyd; John M Deeks; Julie G Arenberg; Robert P Carlyon
Journal:  J Assoc Res Otolaryngol       Date:  2019-06-03

7.  Current Focusing to Reduce Channel Interaction for Distant Electrodes in Cochlear Implant Programs.

Authors:  Lindsay DeVries; Julie G Arenberg
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

8.  Polarity Sensitivity of Human Auditory Nerve Fibers Based on Pulse Shape, Cochlear Implant Stimulation Strategy and Array.

Authors:  Amirreza Heshmat; Sogand Sajedi; Anneliese Schrott-Fischer; Frank Rattay
Journal:  Front Neurosci       Date:  2021-12-08       Impact factor: 4.677

9.  Using Spectral Blurring to Assess Effects of Channel Interaction on Speech-in-Noise Perception with Cochlear Implants.

Authors:  Tobias Goehring; Julie G Arenberg; Robert P Carlyon
Journal:  J Assoc Res Otolaryngol       Date:  2020-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.